期刊文献+

叶酸修饰的奥沙利铂纳米粒的制备及其体外特性研究

Preparation and in vitro Activity Evaluation of Folate-conjugated Nanoparticles Loaded with Oxaliplatin
下载PDF
导出
摘要 目的:制备叶酸修饰的奥沙利铂纳米粒,对其体外特性进行研究。方法:以载药量、包封率为评价指标,对制备叶酸修饰的奥沙利铂纳米粒的方法(包括薄膜分散法、注入法、超声波分散法、逆向蒸发法)进行筛选,再用正交试验优化制备工艺。结果:采用逆向蒸发法制备叶酸修饰的奥沙利铂纳米粒效果较好,纳米粒的平均粒径为(102±53)nm,Zeta电位为(32.5±5.0)mV,载药量为607.79μg/mL,包封率为82.50%,12 h累积释放量为78.6%。结论:本实验所制备的叶酸修饰的奥沙利铂纳米粒包封率较高、稳定性较好,工艺相对简单,具有良好的应用前景。 Objective:To develop folate-conjugated nanoparticles loaded with oxaliplatin (FA-OHP-NP) and evaluate its release characteristics in vitro. Methods : The encapsulation rate and drug loading were used to examine in vitro activity of FA-OHP-NP. Firstly, different methods of FA-OHP-NP preparation were performed to screen, including film dispersion method, injection method, ultrasonic dispersion method, reverse evaporation method, then, orthogonal test was conducted to optimize the preparation. Results:It showed that reverse evaporation method was the best candidate for FA-OHP-NP preparation. The average length of this nanoparticles was ( 105 ± 53 ) nm, the Zata potential value was ( 32.5 ± 5.0 ) mv, the drug loading was 607.79μg/mL, the encapsulation rate was 82.5% and the cumulative release for 12 h was 78.6%. Coneluslons:In the study, the encapsulation rate of FA-OHP-NP was high and its preparation process was sim- ple, stability was good. The potential medical applications are exciting.
出处 《赣南医学院学报》 2013年第6期833-837,共5页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 奥沙利铂纳米粒 体外特性 Nanoparticles loaded with oxaliplatin in vitro activity
  • 相关文献

参考文献19

  • 1林万隆,陈强.奥沙利铂的药理作用及临床应用[J].中国肿瘤临床,2000,27(11):872-874. 被引量:333
  • 2姚智东,吴洪斌.奥沙利铂的安全性评价[J].中国新药杂志,2003,12(7):567-569. 被引量:79
  • 3张伦.铂类抗癌药物市场分析[J].中国药房,2003,14(3):138-140. 被引量:12
  • 4余尧,刘伟平,高文桂,谌喜珠,刘洋.铂类抗癌药物脂质体的研究进展[J].中国新药杂志,2007,16(10):753-757. 被引量:3
  • 5王子妤,张东生.纳米药物的研究进展[J].东南大学学报(医学版),2004,23(2):131-135. 被引量:31
  • 6Uwatoku T, Shimokawa H, Abe K, et al. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats [ J ]. Circulation research, 2003,92 (7) : 62 - 69.
  • 7Moghimi S, Hunter A, Murray J. Long-circulating and tar- get-specific nanoparticles : theory to practice [ J ]. Pharma- cological reviews ,2001,53 (2) :283.
  • 8Hong M,Zhu S,Jiang Y, et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin [ J ]. Journal of Controlled Release, 2009, 133(2) :96 - 102.
  • 9Kennedy M, Jallad K, Lu J, et al. Evaluation of folate con- jugate uptake and transport by the choroid plexus of mice [ J]. Pharmaceutical Research,2003,20(5 ) :714 - 719.
  • 10Stella B, Arpicco S, Peracchia M, et al. Design of folicacid-conjugated nanoparticles for drug targeting [ J ]. Journal of pharmaceutical sciences, 2000,89 ( 11 ) : 1452 - 1464.

二级参考文献114

共引文献491

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部